期刊文献+

苓连消痤丸防治痤疮的药效学实验研究 被引量:3

Study on Pharmacodynamics of Qinlianxiaocuo Pills in Preventing and Curing Acne
下载PDF
导出
摘要 目的:对苓连消痤丸进行药效学研究。方法:用液体-试管法37℃厌氧培养痤疮丙酸杆菌72 h,37℃培养金黄色葡萄球菌18 h,定量测定苓连消痤丸最低抑菌浓度,并观察其对醋酸所致小鼠腹腔毛细血管通透性及巴豆油致炎剂所致小鼠耳廓肿胀的影响。结果:苓连消痤丸对痤丙酸肝茵及金黄色葡萄球菌的最低抑菌浓度分别为0.125 g·ml-1,0.0625 g·ml-1;苓连消痤丸1.5 g·kg-1,3.0 g·kg-1能非常显著地降低醋酸所致小鼠腹腔毛细血管的通透性亢进(P<0.01);减轻巴豆油致炎剂所致小鼠耳廓的肿胀(P<0.01)。结论:苓连消痤丸有明显的抑菌、抗炎作用。 Objective: To study the pharmacodynamic of Qinlianxiaocuo pills. Method: Propinibacterium acnes were anaerobic cultured at 37 ℃ for 72 hours and staphylococus aureus were cultured at 37℃ for 18 hours by liquid-tubal method. Result: The minimum inhibitory concentration of Qinlianxiaocuo pills for propinibacterium acnes and staphylococcus aureus were 0. 125 go·ml^-1 and 0.0625 g·ml^-1 ,respectively, by quantitative determination. Qinlianxiaocuo pills 1.5 g·kg^-1 and 3.0 g·kg^-1 could significantly decrease abdominal capillary permeability induced by acetic acid (P 〈 0.01 ) and ease auricle swelling induced by oil of croton ( P 〈 0.01 ) in mice. Conehlsion: The Qinlianxiaocuo pills had obvious bacteriostatic and anti -inflammatory effects.
机构地区 解放军第
出处 《中国药师》 CAS 2007年第8期802-803,共2页 China Pharmacist
关键词 苓连消痤丸 痤疮丙酸杆菌 金黄色葡萄球菌 抗炎 抑菌 Qinlianxiaocuo pill Propinibacterium acnes Staphylococus aureus Anti - inflammatory action Bacteriostatic action
  • 相关文献

参考文献2

二级参考文献18

  • 1Ross JI, Snelling AM, Eady EA, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U. S.A. , Japan and Australia. Br J Dermatol, 2001, 14
  • 2Nishijima S, Kurokawa I, Katoh N, et al. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. J Dermatol, 2000, 27:318 - 323.
  • 3Tan HH, Goh CL, Yeo MG, et al. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore. Ann Acad Med Singapore, 2001, 30:22-25.
  • 4Eady EA. Bacterial resistance in acne. Dermatology, 1998, 196:59.
  • 5Eady EA, Jones CE, Tipper JL, et al. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage.BMJ, 1993, 306:555 - 556.
  • 6Layton AM. Optimal management of acne to prevent scarring and psychological sequelae. Am J Clin Dermatol, 2001, 2:135 -141.
  • 7Espersen F. Resistance to antibiotics used in dermatological practice.Br J Dermatol, 1998, 139:4-8.
  • 8Westh H, Hougaard DM, Vuust J, et al. Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988. Antimicrob Agents Chemother, 1995, 39(2):369 - 373.
  • 9Ross JI, Eady EA, Cove JH, et al. Resistance to erythromycin and clindamycin in cutaneous propionibaeteria is associated with mutations in 23S rRNA. Dermatology, 1998, 196:69 -70.
  • 10Roberts MC. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution.FEMS Microbiol Rev, 1996, 19:1 -24.

共引文献49

同被引文献33

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部